Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 1113355)

Published in BMJ on June 20, 1998

Authors

K T Khaw

Articles cited by this

Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10

Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ (1997) 6.32

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA (1995) 5.91

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med (1980) 5.23

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med (1991) 3.53

The primary prevention of coronary heart disease in women. N Engl J Med (1995) 3.40

Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1995) 2.58

Postmenopausal estrogen and prevention bias. Ann Intern Med (1991) 2.31

HRT: an analysis of benefits, risks and costs. Br Med Bull (1992) 2.11

Hormone replacement therapy for all? Universal prescription is desirable. BMJ (1996) 1.92

Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol (1979) 1.67

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet (1997) 1.51

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ (1998) 1.48

How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation (1995) 1.26

Hormone replacement therapy and cardiovascular disease. Br Med Bull (1992) 1.13

Nutritional aspects of cardiovascular disease. Report of the Cardiovascular Review Group Committee on Medical Aspects of Food Policy. Rep Health Soc Subj (Lond) (1994) 1.08

Hormone replacement and cancer. Br Med Bull (1992) 1.01

HRT and osteoporosis. Br Med Bull (1992) 0.98

Cultural construction of the menopausal syndrome: the Japanese case. Maturitas (1988) 0.95

The menopause and hormone replacement therapy. Postgrad Med J (1992) 0.77

Articles by these authors

(truncated to the top 100)

General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49

EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer (1999) 9.68

Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet (1994) 4.85

Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32

Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer (1989) 4.01

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79

Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell (1990) 3.29

Milk consumption and bone mineral density in middle aged and elderly women. BMJ (1994) 2.85

The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ (1990) 2.71

Where are the women in studies of coronary heart disease? BMJ (1993) 2.46

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43

Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. J Hypertens (1993) 2.40

The complications of trabeculectomy (a 20-year follow-up). Eye (Lond) (1990) 2.26

Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25

Reproductive failure in males with cystic fibrosis. N Engl J Med (1968) 2.22

Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr (2001) 2.21

A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med (1986) 2.18

A report on sixty-five patients over 17 years of age. Pediatrics (1965) 2.13

Validation of weighed records and other methods of dietary assessment using the 24 h urine nitrogen technique and other biological markers. Br J Nutr (1995) 2.07

Cystic fibrosis: a new outlook. 70 patients above 25 years of age. Medicine (Baltimore) (1977) 2.01

Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia (2009) 1.96

Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med (1987) 1.95

Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics (1970) 1.95

Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia (2013) 1.93

Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol (2005) 1.88

Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia (2012) 1.87

Does lithium carbonate affect the ion transport abnormality in cystic fibrosis? Pediatr Pulmonol (1990) 1.73

Blood pressure and associated factors in a rural Kenyan community. Hypertension (1985) 1.60

Cigarette smoking and increased central adiposity. Ann Intern Med (1989) 1.59

Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia (2007) 1.59

The CAFE computer program for nutritional analysis of the EPIC-Norfolk food frequency questionnaire and identification of extreme nutrient values. J Hum Nutr Diet (2005) 1.59

Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study. J Epidemiol Community Health (2001) 1.56

Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol (2001) 1.56

Population study of blood pressure and associated factors in St Lucia, West Indies. Int J Epidemiol (1982) 1.54

Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr (1995) 1.53

Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia (2010) 1.49

DINER (Data Into Nutrients for Epidemiological Research) - a new data-entry program for nutritional analysis in the EPIC-Norfolk cohort and the 7-day diary method. Public Health Nutr (2001) 1.49

Correlated measurement error--implications for nutritional epidemiology. Int J Epidemiol (2004) 1.49

Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation (1988) 1.47

Quantitative assay of disaccharidase activities of small intestinal mucosal biopsy specimens in infancy and childhood. Pediatrics (1965) 1.46

IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer (2006) 1.39

Area deprivation predicts lung function independently of education and social class. Eur Respir J (2004) 1.37

Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol (2004) 1.37

Family history of diabetes identifies a group at increased risk for the metabolic consequences of obesity and physical inactivity in EPIC-Norfolk: a population-based study. The European Prospective Investigation into Cancer. Int J Obes Relat Metab Disord (2000) 1.37

Tea drinking and bone mineral density in older women. Am J Clin Nutr (2000) 1.36

Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia (2012) 1.29

Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC-Norfolk Study. Eur J Clin Nutr (2001) 1.29

Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care (2000) 1.28

The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia (2012) 1.28

Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol (1992) 1.27

Predictors of stroke-associated mortality in the elderly. Stroke (1984) 1.25

Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol (1989) 1.23

Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study. Bone (2000) 1.23

Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol (1988) 1.22

Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study. Diabetologia (2012) 1.17

Genetic predisposition to obesity leads to increased risk of type 2 diabetes. Diabetologia (2011) 1.17

The diagnostic contribution of the frontal lumbar spine radiograph in community referred low back pain--a prospective study of 1030 patients. Clin Radiol (2003) 1.16

The use of corticosteroids in celiac crisis. J Pediatr (1972) 1.15

Fat consumption and HbA(1c) levels: the EPIC-Norfolk study. Diabetes Care (2001) 1.15

A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. Cancer Res (1990) 1.14

Blood pressure and its correlates in an African tribe in urban and rural environments. J Epidemiol Community Health (1984) 1.13

Plasma vitamin C levels in men and women from different ethnic backgrounds living in England. Int J Epidemiol (1999) 1.12

Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis (1976) 1.12

Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. Pediatrics (1975) 1.12

Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int (2001) 1.12

Blood pressure and casual urine electrolytes in 93 London factory workers. Clin Sci (Lond) (1983) 1.11

Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study. Int J Cancer (2012) 1.10

Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil (2007) 1.10

Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporos Int (2002) 1.08

Dietary fish intake and plasma phospholipid n-3 polyunsaturated fatty acid concentrations in men and women in the European Prospective Investigation into Cancer-Norfolk United Kingdom cohort. Am J Clin Nutr (2006) 1.08

Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08

Dehydroepiandrosterone sulfate and mortality in elderly men and women. J Clin Endocrinol Metab (2001) 1.08

Sex hormones and bone mineral density in elderly men. Bone Miner (1993) 1.07

Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis. Osteoporos Int (1997) 1.06

Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol (1986) 1.05

Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2012) 1.05

An association between respiratory function and hip bone mineral density in older men: a cross-sectional study. Osteoporos Int (2004) 1.05

Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol (1990) 1.04

Vitamin C status and respiratory function. Eur J Clin Nutr (1996) 1.03

Cigarette smoking and increased endogenous estrogen levels in men. Am J Epidemiol (1987) 1.03

Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan. Circulation (1994) 1.03

Randomised double-blind cross-over trial of potassium on blood-pressure in normal subjects. Lancet (1982) 1.02

Blood pressure in 15- to 16-year-old adolescents of different ethnic groups in two London schools. Postgrad Med J (1983) 1.02

Management of pneumothorax in cystic fibrosis. J Pediatr Surg (1983) 1.02

Age-associated bone loss in men and women and its relationship to weight. Age Ageing (1994) 1.01

Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans. Ann Oncol (2012) 1.00

Is hypertension more benign when associated with obesity? Circulation (1985) 1.00

An association between respiratory function and bone mineral density in women from the general community: a cross sectional study. Osteoporos Int (2002) 1.00

Body composition and bone mass in post-menopausal women. Clin Endocrinol (Oxf) (1992) 0.99

Dietary fat intake in the European Prospective Investigation into Cancer and Nutrition: results from the 24-h dietary recalls. Eur J Clin Nutr (2009) 0.99

More acidic dietary acid-base load is associated with reduced calcaneal broadband ultrasound attenuation in women but not in men: results from the EPIC-Norfolk cohort study. Am J Clin Nutr (2007) 0.99

Congenital sucrase-isomaltase deficiency. Observations over a period of 6 years. Pediatrics (1972) 0.97

Which doctors die first? Lower mean age at death in doctors of Indian origin may reflect different age structures. BMJ (1997) 0.97

Lactase deficiency in patients with cystic fibrosis. Pediatrics (1968) 0.96

Blood pressure and contraceptive use. Br Med J (Clin Res Ed) (1982) 0.95

Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol (2013) 0.94

Hip section modulus, a measure of bending resistance, is more strongly related to reported physical activity than BMD. Osteoporos Int (2003) 0.93

Bronchial artery embolization in cystic fibrosis; technique and long-term results. J Pediatr (1979) 0.93